ASCO 2019

Meeting Coverage

ASCO 2019 VIDEO: J. Leonard Lichtenfeld, MD

by Physicians Weekly | Jul 10, 2019 | ASCO 2019, Meeting Coverage | 0 |

J. Leonard Lichtenfeld, MD, Acting Chief Medical and Scientific Officer, American Cancer...

Dr. Diefenbach and Dr. Dale

by Physicians Weekly | Jul 10, 2019 | ASCO 2019, Meeting Coverage | 0 |
ASCO 2019 VIDEO: Monica M. Bertagnolli, MD, Immediate Past-President, ASCO

by Physicians Weekly | Jul 10, 2019 | ASCO 2019, Meeting Coverage | 0 |
ASCO 2019 Clinical Challenge: Are You an ASCO 2019 Expert?

by Physicians Weekly | Jun 17, 2019 | ASCO 2019, Meeting Coverage | 0 |
ASCO 2019 VIDEO: Richard L. Schilsky, MD

by Physicians Weekly | Jun 17, 2019 | ASCO 2019, Meeting Coverage | 0 |

Other Meeting Coverage

ASCO 2019 VIDEO: Debu Tripathy, MD

ASCO 2019 VIDEO: Debu Tripathy, MD

Jun 17, 2019

ASCO 2019: It Really Is All About the Targets

ASCO 2019: It Really Is All About the Ta...

Jun 14, 2019

ASCO 2019: Investigational AKT Inhibitor Holds Promise in ER+ Disease

ASCO 2019: Investigational AKT Inhibitor...

Jun 5, 2019

ASCO 2019: Test All Triple Negative Breast Cancer Patients for PD-L1

ASCO 2019: Test All Triple Negative Brea...

Jun 5, 2019

ASCO 2019: Palbociclib Extends PFS in Young Women with HR+/HER2 Metastatic Breast Cancer

ASCO 2019: Palbociclib Extends PFS in Yo...

Jun 5, 2019

ASCO 2019: NALA III Results Find ‘Modest Benefit’ for Neratinib Plus Capecitabine in Metastatic Breast Cancer

ASCO 2019: NALA III Results Find ‘Modest...

Jun 5, 2019

ASCO 2019: A Metavivor Offers Advice to Clinicians Treating Metastatic Breast Cancer

ASCO 2019: A Metavivor Offers Advice to ...

Jun 5, 2019

ASCO 2019: SOPHIA Findings Pave Way for a New Tx Option in HER2+ Metastatic Breast Cancer

ASCO 2019: SOPHIA Findings Pave Way for ...

Jun 5, 2019

ASCO 2019: CDK4/6 Inhibitors New Standard of Care for First-Line Tx

ASCO 2019: CDK4/6 Inhibitors New Standar...

Jun 4, 2019

ASCO 2019: Researchers Hunt for Breast Cancer Resistance Genes

ASCO 2019: Researchers Hunt for Breast C...

Jun 4, 2019

ASCO 2019: Right to Try Act a Dud?

ASCO 2019: Right to Try Act a Dud?

Jun 4, 2019

ASCO 2019: Adding Clinical Risk to Gene Scoring Predicts Likelihood of Breast Cancer Recurrence

ASCO 2019: Adding Clinical Risk to Gene ...

Jun 4, 2019

ASCO 2019: Olaparib Finds a Place to Treat Prostate Cancer

ASCO 2019: Olaparib Finds a Place to Tre...

Jun 4, 2019

ASCO 2019: Men and Women Doctors Report Sexual Harassment

ASCO 2019: Men and Women Doctors Report ...

Jun 3, 2019

ASCO 2019: FDA Launches Project Facilitate to Ease Access to Novel Agents

ASCO 2019: FDA Launches Project Facilita...

Jun 3, 2019

ASCO 2019: New Agent Targets Metastatic Bladder Cancer

ASCO 2019: New Agent Targets Metastatic ...

Jun 3, 2019

ASCO 2019: Laparoscopy for Liver Mets Equals Open Surgery

ASCO 2019: Laparoscopy for Liver Mets Eq...

Jun 3, 2019

ASCO 2019: PARP-Inhibitor Achieves ‘Complete Response’ in Pancreatic Cancer

ASCO 2019: PARP-Inhibitor Achieves ‘Comp...

Jun 3, 2019

ASCO 2019: Studies Offer Evidence—ACA Improves Care

ASCO 2019: Studies Offer Evidence—ACA Im...

Jun 3, 2019

ASCO 2019: ENZAMET and TITAN Are Wins in Prostate Cancer

ASCO 2019: ENZAMET and TITAN Are Wins in...

Jun 2, 2019

ASCO 2019: Metformin No Help in Advanced Prostate Cancer

ASCO 2019: Metformin No Help in Advanced...

Jun 2, 2019

ASCO 2019: Ribociclib Claims First Ever Overall Survival Benefit for Targeted Therapy. MONALEESA 7 confirms CDK4/6 inhibitor efficacy in younger women

ASCO 2019: Ribociclib Claims First Ever ...

Jun 2, 2019

ASCO 2019: Getting on the Same Page with mCODE. ASCO unveils initiative to topple EHR ‘Tower of Babel’

ASCO 2019: Getting on the Same Page with...

Jun 1, 2019

ASCO 2019: Pembrolizumab Changes ‘the Conversation’ in GI Cancer

ASCO 2019: Pembrolizumab Changes ‘the Co...

Jun 1, 2019

ASCO 2019: Diet to Prevent Breast Cancer Death, Precision Medicine, and More

ASCO 2019: Diet to Prevent Breast Cancer...

May 20, 2019

ASCO 2019: Pediatric Precision Medicine: First Find the Target. Studies Suggest Age Is No Barrier to Targeted Therapy

ASCO 2019: Pediatric Precision Medicine:...

May 20, 2019

ASCO 2019: Determining Dose: It’s All About the Patient When the Patient Is Older and Frail, Consider Low Dose

ASCO 2019: Determining Dose: It’s All Ab...

May 20, 2019

ASCO 2019: What to Expect When 32,000 Cancer Experts Arrive in the Windy City

ASCO 2019: What to Expect When 32,000 Ca...

May 20, 2019

ASCO 2019: Can a Dietary Intervention Prevent Breast Cancer Deaths? A Long Look Back at the Women’s Health Initiative Offers an Answer

ASCO 2019: Can a Dietary Intervention Pr...

May 20, 2019

ASCO 2019: Lenalidomide May Prevent Smoldering Multiple Myeloma from Progressing. But the Treatment Is Toxic

ASCO 2019: Lenalidomide May Prevent Smol...

May 20, 2019